search
Back to results

The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial (TOPHR HIT) (TOPHR HIT)

Primary Purpose

Traumatic Brain Injury

Status
Completed
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
hypertonic saline mixed Dextran
Saline solution
Sponsored by
Sunnybrook Health Sciences Centre
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Traumatic Brain Injury focused on measuring resuscitation

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥16
  • Initial assessment of Glasgow Coma Score (GCS) 8 or less
  • Blunt traumatic mechanism of injury

Exclusion Criteria:

  • Known pregnancy
  • Penetrating primary injury
  • VSA prior to randomization; previous intravenous therapy ≥ 50 ml
  • Time interval between arrival at scene and intravenous access exceeds four hours
  • Amputation of above wrist or ankle
  • Any burn (thermal, chemical, electrical, radiation)
  • Suspected hypothermia
  • Asphyxia (strangulation, hanging, choking, suffocation, drowning) and fall from height ≤ 1m or ≤ 5 stairs.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Placebo Comparator

    Arm Label

    hypertonic saline mixed Dextran

    Placebo controlled

    Arm Description

    hypertonic saline mixed Dextran

    Saline solution

    Outcomes

    Primary Outcome Measures

    30 day survival

    Secondary Outcome Measures

    Survival
    •Survival: 48 hours after admission; Hospital discharge
    Functional neurological outcomes at 4 months
    Neuropsychological testing at 4 months
    Neuropsychological testing at 1 year
    Physiologic parameters indicative of organ dysfunction
    Structural parameters indicative of brain injury or dysfunction at 4 months
    Serum inflammatory markers measured on arrival, 12, 24, 48 hours later

    Full Information

    First Posted
    July 11, 2012
    Last Updated
    July 13, 2012
    Sponsor
    Sunnybrook Health Sciences Centre
    Collaborators
    Defence Research and Development Canada
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT01642524
    Brief Title
    The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial (TOPHR HIT)
    Acronym
    TOPHR HIT
    Official Title
    The Toronto Prehospital Hypertonic Resuscitation-Head Injury and Multi Organ Dysfunction Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2012
    Overall Recruitment Status
    Completed
    Study Start Date
    April 2004 (undefined)
    Primary Completion Date
    January 2006 (Actual)
    Study Completion Date
    July 2011 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Sunnybrook Health Sciences Centre
    Collaborators
    Defence Research and Development Canada

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The TOPHR HIT trial is a clinical trial of patients experiencing blunt trauma who present with an injury to their head which makes them unconscios. The study compares two different fluids given to the patient in the out of hospital setting by a paramedic. The two fluids are salt water (standard treatment) versus a higher concentration of salt water mixed with a sugar (study fluid). The patients have an equal chance of receiving either fluid and the paramedic and the patient and the treating trauma surgeon do not know which fluid was provided in the out of hospital setting.
    Detailed Description
    Study Objective The primary objective of this study is to report feasibility in accordance with the methodology described by Lancaster and Dodds, specifically addressing: baseline survival rates for the treatment and control group to aid in the design of a definitive multicentre trial. randomization compliance rate. ease of protocol implementation in the out-of-hospital setting. adverse rate of Hypertonic Saline Dextran (HSD) infusion. The secondary objectives include measuring the effect of HSD in modulating the immuno-inflammatory response to severe head injury and its effect on modulating the release of neuro-biomarkers into serum; evaluating the role of serum neuro-biomarkers in predicting patient outcome and clinical response to HSD intervention; evaluating effects of HSD on brain atrophy post-injury and neurocognitive and neuropsychological outcomes.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Traumatic Brain Injury
    Keywords
    resuscitation

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 3
    Interventional Study Model
    Single Group Assignment
    Masking
    ParticipantCare Provider
    Allocation
    Randomized
    Enrollment
    114 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    hypertonic saline mixed Dextran
    Arm Type
    Experimental
    Arm Description
    hypertonic saline mixed Dextran
    Arm Title
    Placebo controlled
    Arm Type
    Placebo Comparator
    Arm Description
    Saline solution
    Intervention Type
    Biological
    Intervention Name(s)
    hypertonic saline mixed Dextran
    Intervention Description
    single dose administered intravenously
    Intervention Type
    Biological
    Intervention Name(s)
    Saline solution
    Intervention Description
    placebo - saline solution
    Primary Outcome Measure Information:
    Title
    30 day survival
    Time Frame
    30 days after discharge
    Secondary Outcome Measure Information:
    Title
    Survival
    Description
    •Survival: 48 hours after admission; Hospital discharge
    Time Frame
    48 hrs after admission
    Title
    Functional neurological outcomes at 4 months
    Time Frame
    4 Months
    Title
    Neuropsychological testing at 4 months
    Time Frame
    4 months
    Title
    Neuropsychological testing at 1 year
    Time Frame
    1 year
    Title
    Physiologic parameters indicative of organ dysfunction
    Time Frame
    4 months
    Title
    Structural parameters indicative of brain injury or dysfunction at 4 months
    Time Frame
    4 months
    Title
    Serum inflammatory markers measured on arrival, 12, 24, 48 hours later
    Time Frame
    12, 24, 48 hours later

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    16 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Age ≥16 Initial assessment of Glasgow Coma Score (GCS) 8 or less Blunt traumatic mechanism of injury Exclusion Criteria: Known pregnancy Penetrating primary injury VSA prior to randomization; previous intravenous therapy ≥ 50 ml Time interval between arrival at scene and intravenous access exceeds four hours Amputation of above wrist or ankle Any burn (thermal, chemical, electrical, radiation) Suspected hypothermia Asphyxia (strangulation, hanging, choking, suffocation, drowning) and fall from height ≤ 1m or ≤ 5 stairs.

    12. IPD Sharing Statement

    Learn more about this trial

    The Toronto Prehospital Hypertonic Resuscitation Head Injury and Multi Organ Dysfunction Trial (TOPHR HIT)

    We'll reach out to this number within 24 hrs